Cycle’s partner the Social Medwork BV provides named patient basis access to its nitisinone products in Bangladesh, India, Pakistan and Sudan. For further information on this program please contact the Social Medwork BV.

Cycle may be able to assist physicians and other HCPs obtain our marketed products through our named-patient program or other qualifying programs, depending on the patient’s specific circumstances. These programs are for eligible patients who do not have access to our medications primarily due to economic challenges. For further information regarding eligibility requirements please visit the Cycle NITYR® and Cycle Vita websites.